Literature DB >> 32369454

GPx3 dysregulation impacts adipose tissue insulin receptor expression and sensitivity.

Robert Hauffe1,2, Vanessa Stein1,2, Chantal Chudoba1,2, Tanina Flore1,2, Michaela Rath1,2, Katrin Ritter1,2, Mareike Schell1,2, Kristina Wardelmann1,2, Stefanie Deubel3, Johannes Florian Kopp4,5, Maria Schwarz5,6, Kai Kappert7, Matthias Blüher8, Tanja Schwerdtle4,5, Anna P Kipp5,6, André Kleinridders1,2,9.   

Abstract

Insulin receptor signaling is crucial for white adipose tissue (WAT) function. Consequently, lack of insulin receptor (IR) in WAT results in a diabetes-like phenotype. Yet, causes for IR downregulation in WAT of patients with diabetes are not well understood. By using multiple mouse models of obesity and insulin resistance, we identify a common downregulation of IR with a reduction of mRNA expression of selenoproteins Txnrd3, Sephs2, and Gpx3 in gonadal adipose tissue. Consistently, GPX3 is also decreased in adipose tissue of insulin-resistant and obese patients. Inducing Gpx3 expression via selenite treatment enhances IR expression via activation of the transcription factor Sp1 in 3T3-L1 preadipocytes and improves adipocyte differentiation and function. Feeding mice a selenium-enriched high-fat diet alleviates diet-induced insulin resistance with increased insulin sensitivity, decreased tissue inflammation, and elevated IR expression in WAT. Again, IR expression correlated positively with Gpx3 expression, a phenotype that is also conserved in humans. Consequently, decreasing GPx3 using siRNA technique reduced IR expression and insulin sensitivity in 3T3-L1 preadipocytes. Overall, our data identify GPx3 as a potentially novel regulator of IR expression and insulin sensitivity in adipose tissue.

Entities:  

Keywords:  Adipose tissue; Endocrinology; Insulin signaling; Metabolism; Obesity

Mesh:

Substances:

Year:  2020        PMID: 32369454      PMCID: PMC7308064          DOI: 10.1172/jci.insight.136283

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  59 in total

1.  Effects of Weight Loss on Glutathione Peroxidase 3 Serum Concentrations and Adipose Tissue Expression in Human Obesity.

Authors:  Julia Langhardt; Gesine Flehmig; Nora Klöting; Stefanie Lehmann; Thomas Ebert; Matthias Kern; Michael R Schön; Daniel Gärtner; Tobias Lohmann; Miriam Dressler; Mathias Fasshauer; Peter Kovacs; Michael Stumvoll; Arne Dietrich; Matthias Blüher
Journal:  Obes Facts       Date:  2018-12-11       Impact factor: 3.942

Review 2.  Epidemiology of selenium and type 2 diabetes: can we make sense of it?

Authors:  Margaret P Rayman; Saverio Stranges
Journal:  Free Radic Biol Med       Date:  2013-04-16       Impact factor: 7.376

3.  A high-selenium diet induces insulin resistance in gestating rats and their offspring.

Authors:  Min-Shu Zeng; Xi Li; Yan Liu; Hua Zhao; Ji-Chang Zhou; Ke Li; Jia-Qiang Huang; Lv-Hui Sun; Jia-Yong Tang; Xin-Jie Xia; Kang-Ning Wang; Xin Gen Lei
Journal:  Free Radic Biol Med       Date:  2012-02-01       Impact factor: 7.376

Review 4.  Biological activity of selenium: Revisited.

Authors:  Jagoda K Wrobel; Ronan Power; Michal Toborek
Journal:  IUBMB Life       Date:  2015-12-30       Impact factor: 3.885

5.  Glutathione peroxidase 3 serum levels and GPX3 gene polymorphisms in subjects with metabolic syndrome.

Authors:  Blanca G Baez-Duarte; Francisco Mendoza-Carrera; Alejandra García-Zapién; Silvia E Flores-Martínez; José Sánchez-Corona; Irma Zamora-Ginez; Enrique Torres-Rasgado; Bertha A León-Chávez; Ricardo Pérez-Fuentes
Journal:  Arch Med Res       Date:  2014-05-10       Impact factor: 2.235

Review 6.  Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.

Authors:  Adilson Guilherme; Joseph V Virbasius; Vishwajeet Puri; Michael P Czech
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

7.  High selenium intake and increased diabetes risk: experimental evidence for interplay between selenium and carbohydrate metabolism.

Authors:  Holger Steinbrenner; Bodo Speckmann; Antonio Pinto; Helmut Sies
Journal:  J Clin Biochem Nutr       Date:  2010-12-28       Impact factor: 3.114

8.  Selenium-binding protein 1 (SELENBP1) is a marker of mature adipocytes.

Authors:  Holger Steinbrenner; Mustafa Micoogullari; Ngoc Anh Hoang; Ina Bergheim; Lars-Oliver Klotz; Helmut Sies
Journal:  Redox Biol       Date:  2018-11-10       Impact factor: 11.799

9.  Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation.

Authors:  Gesine Flehmig; Markus Scholz; Nora Klöting; Mathias Fasshauer; Anke Tönjes; Michael Stumvoll; Byung-Soo Youn; Matthias Blüher
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

10.  Differential Roles of Insulin and IGF-1 Receptors in Adipose Tissue Development and Function.

Authors:  Jeremie Boucher; Samir Softic; Abdelfattah El Ouaamari; Megan T Krumpoch; Andre Kleinridders; Rohit N Kulkarni; Brian T O'Neill; C Ronald Kahn
Journal:  Diabetes       Date:  2016-05-13       Impact factor: 9.461

View more
  14 in total

Review 1.  Selenium and Selenoproteins at the Intersection of Type 2 Diabetes and Thyroid Pathophysiology.

Authors:  Francesca Gorini; Cristina Vassalle
Journal:  Antioxidants (Basel)       Date:  2022-06-16

2.  Obesity Hinders the Protective Effect of Selenite Supplementation on Insulin Signaling.

Authors:  Robert Hauffe; Michaela Rath; Wilson Agyapong; Wenke Jonas; Heike Vogel; Tim J Schulz; Maria Schwarz; Anna P Kipp; Matthias Blüher; André Kleinridders
Journal:  Antioxidants (Basel)       Date:  2022-04-28

3.  Increased Adipose Tissue Indices of Androgen Catabolism and Aromatization in Women With Metabolic Dysfunction.

Authors:  Giada Ostinelli; Sofia Laforest; Scott G Denham; Marie-Frederique Gauthier; Virginie Drolet-Labelle; Emma Scott; Frédéric-Simon Hould; Simon Marceau; Natalie Z M Homer; Catherine Bégin; Ruth Andrew; André Tchernof
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

4.  Transcriptomic Profiles of Splenic CD19+ B Cells in Mice Chronically Infected With the Larval Echinococcus granulosus.

Authors:  Shiping Xu; Yuxin Guo; Tiancheng Luo; Pengfei Jiang; Ziyi Yan; Yan He; Linlin Fu; Hua Liu; Zixuan Gao; Dingmin Wang; Zhengxiu Sun; Xiaoying Yang; Wei Pan; Fenfen Sun
Journal:  Front Vet Sci       Date:  2022-04-25

5.  Systemic inflammation is negatively associated with early post discharge growth following acute illness among severely malnourished children - a pilot study.

Authors:  James M Njunge; Gerard Bryan Gonzales; Moses M Ngari; Johnstone Thitiri; Robert H J Bandsma; James A Berkley
Journal:  Wellcome Open Res       Date:  2021-03-16

Review 6.  The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities.

Authors:  Holger Steinbrenner; Leonidas H Duntas; Margaret P Rayman
Journal:  Redox Biol       Date:  2022-01-24       Impact factor: 11.799

Review 7.  The Role of Selenoprotein Tissue Homeostasis in MetS Programming: Energy Balance and Cardiometabolic Implications.

Authors:  María Luisa Ojeda; Olimpia Carreras; Fátima Nogales
Journal:  Antioxidants (Basel)       Date:  2022-02-15

8.  Identification of Hypoxia Induced Metabolism Associated Genes in Pulmonary Hypertension.

Authors:  Yang-Yang He; Xin-Mei Xie; Hong-Da Zhang; Jue Ye; Selin Gencer; Emiel P C van der Vorst; Yvonne Döring; Christian Weber; Xiao-Bin Pang; Zhi-Cheng Jing; Yi Yan; Zhi-Yan Han
Journal:  Front Pharmacol       Date:  2021-11-05       Impact factor: 5.810

Review 9.  Chemopreventive and Anticancer Property of Selenoproteins in Obese Breast Cancer.

Authors:  Supriya Bevinakoppamath; Adel Mohammed Saleh Ahmed; Shobha Chikkavaddaraguddi Ramachandra; Prashant Vishwanath; Akila Prashant
Journal:  Front Pharmacol       Date:  2021-04-16       Impact factor: 5.810

10.  Tissue-Specific Methylation Biosignatures for Monitoring Diseases: An In Silico Approach.

Authors:  Makrina Karaglani; Maria Panagopoulou; Ismini Baltsavia; Paraskevi Apalaki; Theodosis Theodosiou; Ioannis Iliopoulos; Ioannis Tsamardinos; Ekaterini Chatzaki
Journal:  Int J Mol Sci       Date:  2022-03-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.